How the genetics of lung cancer may overlap with COPD.

scientific article published on October 2011

How the genetics of lung cancer may overlap with COPD. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1440-1843.2011.02019.X
P698PubMed publication ID21749550
P5875ResearchGate publication ID51486069

P50authorRobert YoungQ124161902
P2093author name stringRaewyn J Hopkins
P2860cites workLung cancer susceptibility model based on age, family history and genetic variantsQ21091204
Genome-wide association study identifies five loci associated with lung functionQ24629653
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary functionQ24633262
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association studyQ24644661
The basics of epithelial-mesenchymal transitionQ24652992
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studiesQ24653818
Functional variants of antioxidant genes in smokers with COPD and in those with normal lung functionQ24681700
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and FinlandQ28140600
A short history of lung cancerQ28199299
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokersQ28259916
Survival of patients with stage I lung cancer detected on CT screeningQ28270460
E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPasesQ28385103
Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPDQ28743099
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated researchQ28754732
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Q28943480
A variant associated with nicotine dependence, lung cancer and peripheral arterial diseaseQ29614871
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25Q29614944
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyQ29614971
Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary functionQ30496386
Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-upQ30806378
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathwaysQ30850865
Framingham Heart Study genome-wide association: results for pulmonary function measuresQ33300819
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.Q33419815
A genome-wide association study of pulmonary function measures in the Framingham Heart StudyQ33419839
The COPD genetic association compendium: a comprehensive online database of COPD genetic associationsQ33559787
Variants in FAM13A are associated with chronic obstructive pulmonary diseaseQ33687879
Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary careQ33794627
Smoking and lung cancer: the role of inflammationQ33842487
Developing COPD: a 25 year follow up study of the general populationQ34577485
COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyQ34604212
Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary diseaseQ35694443
Inducible innate resistance of lung epithelium to infectionQ35754472
Genetics of COPD.Q35770021
Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in IcelandQ35906553
Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary diseaseQ36248645
Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"?Q36399326
Rho GTPase activating proteins in cancer phenotypesQ36570345
State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancerQ36571997
The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?Q36863297
Genome-wide association studies provide new insights into type 2 diabetes aetiologyQ36912145
Association of radiographic emphysema and airflow obstruction with lung cancerQ36915507
Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causesQ36955879
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysisQ37083161
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeuticsQ37106945
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like diseaseQ37111384
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary diseaseQ37149401
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.Q37178709
Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoAQ37211163
Current concepts on the role of inflammation in COPD and lung cancerQ37316084
Systemic manifestations and comorbidities of COPD.Q37465879
Chronic inflammation, chronic obstructive pulmonary disease, and lung cancerQ37471392
Immunologic aspects of chronic obstructive pulmonary diseaseQ37506948
Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' researchQ37553688
Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidenceQ37562594
Smoking cessation: the potential role of risk assessment tools as motivational triggersQ37672052
Mechanisms involved in lung cancer development in COPD.Q37800575
Pharmacological actions of statins: potential utility in COPD.Q37801150
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.Q37834029
Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancerQ38296825
Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practiceQ38474511
Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adultsQ39296602
A common familial component in lung cancer and chronic obstructive pulmonary diseaseQ39598779
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.Q39955550
Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signalingQ40098558
Inhibitory effect of statins on renal epithelial-to-mesenchymal transitionQ40250501
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.Q40442526
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancerQ40664922
Airways obstruction and the risk for lung cancerQ41481140
Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease.Q42474300
Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transitionQ42919170
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer riskQ42952638
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohortQ44934998
Lung cancer gene associated with COPD: triple whammy or possible confounding effect?Q46269161
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.Q51898509
Requirement for Rac1 in a K-ras induced lung cancer in the mouse.Q53329326
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer.Q54599241
P433issue7
P921main subjectlung cancerQ47912
P304page(s)1047-1055
P577publication date2011-10-01
P1433published inRespirologyQ15753093
P1476titleHow the genetics of lung cancer may overlap with COPD.
P478volume16

Reverse relations

cites work (P2860)
Q55106203Analysis of the Clinicopathological Characteristics and Risk Factors in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease.
Q36540914Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Q36112558Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer
Q34840130Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era
Q26786812COPD and its comorbidities: Impact, measurement and mechanisms
Q58572012Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer
Q47564926Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls
Q34031235Chronic obstructive pulmonary disease as a risk factor for lung cancer
Q55354282Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer.
Q41604995Circulating tumor cell interactions with macrophages: implications for biology and treatment
Q36320998Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease
Q36695396Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer
Q36878756IL-17 induces EMT via Stat3 in lung adenocarcinoma
Q55005225Low diffusing capacity, emphysema, or pulmonary fibrosis: who is truly pulling the lung cancer strings?
Q88310782Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Q99565824Lung cancer and obstructive lung disease in never smokers
Q38195806Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment
Q34507403Macrophages facilitate coal tar pitch extract-induced tumorigenic transformation of human bronchial epithelial cells mediated by NF-κB.
Q50905501Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
Q52722348Prognostic significance of CT-determined emphysema in patients with small cell lung cancer.
Q39000705Rare variant of MAP2K7 is associated with increased risk of COPD in southern and eastern Chinese
Q33558881Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease
Q37689941Smoking exposure, loss of forced expiratory volume in one second and the risk of lung cancer among patients with malignant disease who present with cardiac or pulmonary symptoms: a cross-sectional study
Q38569752Smoking, inflammation and small cell lung cancer: recent developments
Q34089332State-of-the-art MS technology applications in lung disease.
Q37644907Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
Q41679073The Functional Copy Number Variation-67048 in WWOX Contributes to Increased Risk of COPD in Southern and Eastern Chinese
Q92653813The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly
Q34656726Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.
Q37976117Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer
Q88585706[Clinical characteristics and risk factors affecting outcomes of elderly patients with non-small cell lung cancer complicated by chronic obstructive pulmonary disease]

Search more.